About 2cureX

People are different and so is their cancer, patients should be treated individually.

Our management team

Fernando Andreu CEO

Ole Thastrup CSO and Deputy CEO

Kenneth Graabek Johansen Chief Financial Officer

Grith Hagel Chief Operating Officer

Jürgen Kupper Vice-President of Strategic Alliances

Jesper Floyd Kristiansen VP Global Business Development

Mark C. Gray Director of Communications

Manuel Fernández Quality & Regulatory Director

Raphael Gruber Medical Director

Tabea Sturmheit Director of Research

Jacob Thastrup Director of Product Development

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.